These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38651129)

  • 1. Discussion on the recruitment strategy for apheresis platelet donors in Chongqing during a public health emergency
    Cheng Y; Xie C; Tian Y; Wang F; Liu X; Cheng D
    Front Public Health; 2024; 12():1365433. PubMed ID: 38651129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of platelet yield, donor's characteristic and apheresis instruments in China.
    Yin G; Xu J; Shen Z; Wang Y; Zhu F; Lv H
    Transfus Apher Sci; 2013 Dec; 49(3):608-12. PubMed ID: 23978555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographics of apheresis platelet donors in five blood centers in China.
    Guo N; Wang J; Ness P; Yao F; Dong X; Bi X; Mei H; Li J; He W; Lu Y; Ma H; Wen X; Huang M; Liu J; Wright DJ; Shan H;
    Transfusion; 2012 Mar; 52(3):560-6. PubMed ID: 21895674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plateletpheresis donation through donor awareness, motivation, and recruitment drives: A unique concept and experience from a tertiary care oncology centre in India.
    Ojha S; Gupta AM; Nagaraju P; Poojary M; Ravatale A
    Transfus Clin Biol; 2022 Feb; 29(1):65-69. PubMed ID: 34302952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Indications and Adverse Reactions of Platelet Apheresis.
    Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young apheresis platelet donors show significant and sustained growth over the last decade in the US, 2010-2019: A favorable sign of the resiliency of the platelet supply.
    Lasky B; Singh U; Young PP
    Transfusion; 2023 Jul; 63(7):1333-1343. PubMed ID: 37191295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
    Thiele T; Alt-Mayer T; Greinacher A; Bux J
    Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Frequency of Platelet Apheresis on Coagulation Function in Donors: A Prospective Cohort Study.
    Feng Q; Zhu F; Li C; Guo B; Ye J; Chen J
    Indian J Hematol Blood Transfus; 2019 Oct; 35(4):736-741. PubMed ID: 31741630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Hematological Indices and Lymphocyte Subsets in Response to Platelet Apheresis Donation.
    Borai A; Bahijri S; Almohammadi M; Al-Sofyani A; Baljoon D; Al-Amri A; Boraie S; Ferns G
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.
    de Farias CLG; Bassolli L; Mendrone-Junior A; de Araújo Arrais C; Duran A; Rocha V; de Almeida-Neto C
    Transfus Apher Sci; 2022 Aug; 61(4):103424. PubMed ID: 35346602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China.
    Chen J; Zhou G; Fu X; Li S; Li Y; Kang J; Chen H; Zhou L; Fu Y
    BMC Public Health; 2021 Apr; 21(1):819. PubMed ID: 33926409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.
    Rahmani M; Fortin BM; Berliner N; Issa N; Neuberg D; Kaufman RM; Gansner JM
    Transfusion; 2019 May; 59(5):1644-1647. PubMed ID: 30747442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and attitudes of apheresis donors regarding apheresis blood donation.
    Tarlabelen Karaytuğ E; Boyraz S
    Transfus Med; 2023 Feb; 33(1):39-48. PubMed ID: 35633143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of relative iron deficiency in platelet- and plasma-pheresis donors correlates with donation frequency.
    Li H; Condon F; Kessler D; Nandi V; Rebosa M; Westerman M; Shaz BH; Ginzburg Y
    J Clin Apher; 2016 Dec; 31(6):551-558. PubMed ID: 26915437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of Mild SARS-CoV-2 Infection on Hematological Parameters and Suitability of Apheresis Platelets Donation in Blood Donors].
    Huang SM; Lin XM; Jiang WM; Ji SH; Lin S; Lin HK; Chen C; Chu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):883-889. PubMed ID: 38926984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of serum iron stores in regular plateletpheresis donors.
    Chinigi Sab P; Kaur G; Kaur P; Tahlan A; Bedi RK; Mittal K; Sood T
    Transfus Apher Sci; 2022 Feb; 61(1):103291. PubMed ID: 34649790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.